More Me-Too Products, Not Fewer
An article by our good friend Derek Hennecke in the September issue of Drug Development & Delivery really struck a nerve with us...but in a good way. To quote (with…
Menu
Pharma Competitive Intelligence, Then and Now
Pharmaceutical and biotech competitive intelligence is increasingly important and challenging these days. Lacerta Bio discusses a recent case study in which a client learned this the hard way.
Lacerta Bio at BIO-Europe 2012 in Hamburg
Lacerta Bio is pleased to announce our attendance at the upcoming BIO-Europe 2012 conference in Hamburg, Germany. In our view, the Fall version of BIO-Europe is the premier partnering…
Abandon R&D for M&A? Vote today!
In response to the recent acquisition of Medicis by Valeant, an interesting poll underway asking a seemingly simple question, "Will other pharma companies follow Valeant and abandon R&D in favor…